prism fitting program (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
prism fitting program
Prism Fitting Program, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+computer+program/prism+4+0+computer+fitting+program/pmc03425122-45-12-16
Average 90 stars, based on 1 article reviews
Prism Fitting Program, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+computer+program/prism+4+0+computer+fitting+program/pmc03425122-45-12-16
Average 90 stars, based on 1 article reviews
prism fitting program - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Iodine 125‐labeled mesenchymal–epithelial transition factor binding peptide‐click‐cRGDyk heterodimer for glioma imaging Article Snippet: Binding affinities (IC 50 ) for both receptors were calculated by non‐linear regression analysis (sigmoidal dose‐response equation) using the GraphPad Article Title: Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Article Snippet: Deterioration of vascular reactivity plays a pivotal role in vascular complications.. Pentoxifylline (PTX) is a well-tolerated drug used to treat vascular insufficiency.. We investigated the protective effect of PTX against vascular impairment in insulin resistance. Article Title: Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts. Article Snippet: c-Met is a receptor tyrosine kinase involved in tumor cell growth, invasion, metastases and angiogenesis.. Overexpression of c-Met is frequently observed in several tumor types.. Here, we report the in vitro cell-binding properties and biodistribution and SPECT/CT imaging in glioma (U87MG) xenograft-bearing mice of I-labeled c-Met-binding peptides (cMBPs) including analogs conjugated to amino acid and aliphatic carbon linkers. Binding Assay:Article Title: 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET? Article Snippet: Aim: In the present study we demonstrate the in vitro and in vivo comparison of the Sc and Ga labeled DOTA-BN[2-14]NH2.. Sc is a positron emitter with a half life of 3.92 h. Hence it could be used for PET imaging with ligands requiring longer observation time than in the case of Ga. Methods: The binding affinity of Sc-DOTA-BN[2-14]NH2 and Ga-DOTA-BN[2-14]NH2 to GRP receptors was studied in competition to [I-Tyr]-Bombesin in the human prostate cancer cell line PC-3.. A preliminary biodistribution in normal rats was performed, while first microPET images were assessed in male Copenhagen rats bearing the androgen-independent Dunning R-3327-AT-1 prostate |